Qiagen (QIA), founded in 1984, provides molecular sample and assay solutions globally. Its portfolio includes over 500 products, which can be classified into three categories: Consumables, Instruments and Bioinformatics. Qiagen employs 4,600 people in over 25 countries serving 500,000 customers worldwide. The company’s corporate headquarters are in Venlo, the Netherlands, while their operational headquarters are located in Hilden, Germany. Qiagen stock has a dual listing on the NASDAQ and the Frankfurt Stock Exchange. Explore the performance of the Qiagen stock price at Capital.com.